NEW YORK / RankWire.AI / – Global health authorities convened during a United Nations General Assembly event to emphasize the importance of nations leading the adoption of artificial intelligence in efforts to eliminate diseases. The gathering assembled ministers, public health experts, funders, and diagnostics specialists. The Global Institute for Disease Elimination, also known as GLIDE, co-hosted the conference alongside the RBM Partnership to End Malaria and Nigeria. Key topics included disease monitoring, health system planning, resource distribution, and the prerequisites for responsible AI deployment.
Delegates underscored that governments should take the lead in making decisions about how AI tools are incorporated into health systems. On behalf of Nigeria’s health minister Muhammad Ali Pate, Michael Adekunle Charles, CEO of the RBM Partnership to End Malaria, delivered remarks. Nigeria’s ongoing Health Sector Renewal Investment Initiative addresses primary healthcare, health financing, workforce development, and strengthening data infrastructure. Attendees also stressed the importance of aligning new technological advancements with existing national health priorities.
The discussions focused on the practical needs for expanding AI use within disease control efforts. Participants identified key requirements such as dependable data sources, trained healthcare personnel, sustainable funding, and seamless integration with current systems. Malaria remains a central concern for global health organizations. The World Health Organization estimated that in 2024, there were 282 million malaria cases worldwide, resulting in 610,000 deaths. The WHO African Region bore the majority of this burden, with Nigeria reporting the highest estimated number of malaria cases.
New AI Initiatives Targeting Health Sector Leadership
GLIDE unveiled two new training programs aimed at enhancing artificial intelligence knowledge among public health leaders. Its GLIDE Leadership Excellence in AI for Health initiative will host senior decision-makers in Abu Dhabi from January 17 to 22, 2027. The inaugural residential cohort is expected to comprise 25 to 30 participants. The curriculum will cover AI governance, organizational readiness, deployment strategies, and accountability measures. The program is designed for officials overseeing health policy and national disease programs.
Mohamed bin Zayed University of Artificial Intelligence partnered with GLIDE to develop a second initiative, AI for All, aimed at public health professionals. This online course features four modules and does not require coding experience. It addresses fundamental AI concepts, generative AI, biases, privacy issues, accountability, and human oversight. The training provides health professionals with the groundwork to evaluate AI tools for public health use, including how to assess technology before incorporating it into routine practice.
Malaria Collaboration Incorporates Technical Support
During the New York event, GLIDE and the RBM Partnership to End Malaria formalized a letter of mutual understanding. This agreement aims to connect technical expertise, innovative approaches, and capacity-building efforts with national malaria priorities. It reinforces country-led initiatives to control and eradicate malaria. Additionally, the partnership aligns with the World Health Organization’s Global Technical Strategy for Malaria, which directs international efforts to reduce malaria cases and fatalities through 2030 while bolstering surveillance and health systems.
Broader conversations also included polio and neglected tropical diseases alongside malaria. Participants examined how AI can enhance disease surveillance, inform program decisions, and optimize resource allocation. The event kept national health authorities at the forefront of technological decision-making. Organizers emphasized the importance of training and institutional capacity as countries explore new digital tools. The initiatives announced in New York linked AI education, technical cooperation, and national leadership with ongoing efforts to eliminate preventable infectious diseases.